2013 ACES Program Book (in PDF) - The University of Texas at ...
PDF) Kappa-opioid receptors differentially regulate low and high levels of ethanol intake in female mice
A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction - ScienceDirect
Prefrontal Parvalbumin Neurons in Control of Attention
PDF) Ventral Tegmental Area GABA, glutamate, and glutamate-GABA neurons are heterogenous in their electrophysiological and pharmacological properties
CDH2 mutation affecting N-cadherin function causes attention-deficit hyperactivity disorder in humans and mice
Monday, December 4, 2006 Panel Session Co-Morbid Pain and Addiction: Novel Treatments
Cloning and pharmacological characterization of a rat kappa opioid receptor.
![PDF] Addiction: Beyond dopamine reward circuitry | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2f4e36a53241878d776c926543f73d2fee5a38e2/4-Figure5-1.png "PDF] Addiction: Beyond dopamine reward circuitry | Semantic Scholar")
PDF] Addiction: Beyond dopamine reward circuitry | Semantic Scholar
CDH2 mutation affecting N-cadherin function causes attention-deficit hyperactivity disorder in humans and mice
Characterization of a Knock-In Mouse Line Expressing a Fusion Protein of κ Opioid Receptor Conjugated with tdTomato: 3-Dimensio
An update on extra-oral bitter taste receptors
(PDF) TBHQ Attenuates Neurotoxicity Induced by Methamphetamine in the VTA through the Nrf2/HO-1 and PI3K/AKT Signaling Pathways
PDF) An update on extra-oral bitter taste receptors
Kappa Opioid Inhibition of Somatodendritic Dopamine Inhibitory Postsynaptic Currents
PDF) Mesolimbic Functional Magnetic Resonance Imaging Activations during Reward Anticipation Correlate with Reward-Related Ventral Striatal Dopamine Release
PDF) Ventral tegmental area GABAergic inhibition of cholinergic interneurons in the ventral nucleus accumbens shell promotes reward reinforcement
PDF) Ventral tegmental area GABAergic inhibition of cholinergic interneurons in the ventral nucleus accumbens shell promotes reward reinforcement
Howard FIELDS | Professor | MD PhD | University of California, San Francisco, CA | UCSF | Department of Neurology
CDH2 mutation affecting N-cadherin function causes attention-deficit hyperactivity disorder in humans and mice
PDF) Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated Κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor
Untitled
Untitled
PDF) TBHQ Attenuates Neurotoxicity Induced by Methamphetamine in the VTA through the Nrf2/HO-1 and PI3K/AKT Signaling Pathways
Untitled
